Overview
- Labour MP Jonathan Hinder and other parliamentarians have urged Health Secretary Wes Streeting to stop the plan, with Hinder calling it an “immoral experiment.”
- Conservative leader Kemi Badenoch has also demanded the trial be abandoned immediately.
- The Department of Health says proceeding aligns with the Cass Review, which found a weak evidence base and recommended formal research.
- Researchers at King’s College London plan to enroll about 220 to 226 participants under 16, comparing two years of suppression with a one-year delay before treatment.
- Eligibility requires having begun puberty, meeting strict clinical criteria, intensive medical and psychological screening, and informed consent from the young person and a parent or guardian, against the backdrop of a UK-wide ban on routine prescribing.